WASHINGTON, DC – The National Breast Cancer Coalition is proud to announce bipartisan support for a bill to waive onerous […]
“Changes to FDA warnings and labeling should be grounded in rigorous, contemporary evidence—not post-hoc or subgroup re-analyses of older trials. ”
“As a breast cancer survivor, [Visco] turned pain into purpose, changed the landscape of breast cancer advocacy, and has become a powerful symbol of hope for the nation.”
Nicole Levins, communications director
nlevins@stopbreastcancer.org
WASHINGTON, DC – The National Breast Cancer Coalition is proud to announce bipartisan support for a bill to waive onerous […]
NBCC Statement on the Passing of Congressman Alcee Hastings We have lost another leader in our mission to end breast […]
FDA Accelerated Approval: How will we get drugs that work? NBCC advocates have been excited about the promise of immunotherapy […]
A Closer Look at the DOD Breast Cancer Research Program The Department of Defense (DOD) has operated the peer-reviewed Breast […]
Sign of Progress at the FDA? NBCC has long pushed for drug approvals based on clinically-significant outcomes: meaningful improvements in […]
